1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR

mTOR (哺乳动物雷帕霉素靶蛋白)

Mammalian target of Rapamycin

mTOR (mammalian target of Rapamycin) is a protein that in humans is encoded by the mTOR gene. mTOR is a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. mTOR belongs to the phosphatidylinositol 3-kinase-related kinase protein family. mTOR integrates the input from upstream pathways, including growth factors and amino acids. mTOR also senses cellular nutrient, oxygen, and energy levels. The mTOR pathway is dysregulated in human diseases, such as diabetes, obesity, depression, and certain cancers. Rapamycin inhibits mTOR by associating with its intracellular receptor FKBP12. The FKBP12-rapamycin complex binds directly to the FKBP12-Rapamycin Binding (FRB) domain of mTOR, inhibiting its activity.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-146751
    PI3K/Akt/mTOR-IN-2 Inhibitor 99.86%
    PI3K/Akt/mTOR-IN-2 是一种有效的 PI3K/AKT/mTOR 抑制剂。PI3K/Akt/mTOR-IN-2 具有抗癌作用,并对 MDA-MB-231 细胞具有选择性,IC50 为 2.29 μM。PI3K/Akt/mTOR-IN-2 可诱导癌细胞周期阻滞和细胞凋亡 (apoptosis)。
    PI3K/Akt/mTOR-IN-2
  • HY-N0486S9
    L-Leucine-d3

    L-亮氨酸-d3

    Activator ≥98.0%
    L-Leucine-d3 是 L-Leucine 的氘代物。L-Leucine 是一种必需的支链氨基酸 (BCAA),可激活 mTOR 信号通路。
    L-Leucine-d<sub>3</sub>
  • HY-107365
    PQR530 Inhibitor 99.98%
    PQR530 是一种有效,ATP竞争性的,具有口服活性,可透过血脑屏障的,PI3K/mTORC1/2 双重抑制剂,对于 PI3KαmTOR (分别为 0.84 和 0.33 nM) 的 Kd 为亚摩尔。具有抗肿瘤活性。
    PQR530
  • HY-16962A
    CC-115 hydrochloride Inhibitor 98.03%
    CC-115 hydrochloride 是一种有效的双重 DNA-PKmTOR 抑制剂,IC50 分别为 13 nM 和 21 nM。CC-115 阻断 mTORC1mTORC2 信号通路。
    CC-115 hydrochloride
  • HY-12034
    WYE-354 Inhibitor 98.04%
    WYE-354 是一种 ATP 竞争性的 mTOR 抑制剂,IC50 为 5 nM。WYE-354 也抑制 PI3KαPI3KγIC50 分别为 1.89 μM 和 7.37 μM。WYE-354 抑制 mTORC1mTORC2。WYE-354 在体外能诱导自噬 (autophagy) 激活.
    WYE-354
  • HY-N0656A
    (+)-Usnic acid

    (+)-地衣酸

    Inhibitor 99.63%
    (+)-Usnic acid 为地衣中的有效成分,可结合 mTOR 的 ATP 结合口袋,抑制 mTORC1/2 的活性。(+)-Usnic acid 可抑制 mTOR 下游效应蛋白 Akt (Ser473),4EBP1 和 S6K 的磷酸化水平,诱导自噬 (autophay),具有抗肿瘤活性。(+)-Usnic acid 对许多浮游革兰氏阳性细菌具有抗菌活性,包括金黄色葡萄球菌、粪肠球菌和粪肠球菌。
    (+)-Usnic acid
  • HY-12763
    GNE-317 Inhibitor 99.14%
    GNE-317 是一种 PI3K/mTOR 抑制剂,能够穿过血脑屏障 (BBB)。
    GNE-317
  • HY-10219S
    Rapamycin-d3

    雷帕霉素 d3

    Inhibitor
    Rapamycin-d3Rapamycin (HY-10219)的氘代物。Rapamycin 是一种有效且特异性的 mTOR 抑制剂,作用于 HEK293 细胞,抑制 mTOR, IC50 为 0.1 nM。Rapamycin 与 FKBP12 结合且抑制 mTORC1。Rapamycin 还是一种自噬 (autophagy) 激活剂,免疫抑制剂。
    Rapamycin-d<sub>3</sub>
  • HY-N6996
    Methyl Eugenol

    甲基丁香酚

    Inhibitor 98.64%
    Methyl Eugenol 是一种具有口服活性的东方果类小实蝇 (Hendel) 的诱捕剂。Methyl Eugenol 具有抗癌和抗炎活性。Methyl Eugenol 能诱导细胞自噬。Methyl Eugenol 可以用于肠缺血/再灌注损伤的研究。
    Methyl Eugenol
  • HY-15248
    GDC-0349 Inhibitor
    GDC-0349 是一种有效的,ATP竞争性的选择性 mTOR 抑制剂,Ki 值为 3.8 nM。GDC-0349 抑制 mTORC1mTORC2 复合体。
    GDC-0349
  • HY-10115A
    PI-103 Hydrochloride Inhibitor 98.00%
    PI-103 Hydrochloride 是一种有效的 PI3K mTOR 抑制剂,抑制 p110αp110βp110δp110γmTORC1mTORC2IC50 分别为 8 nM,88 nM,48 nM,150 nM,20 nM 和 83 nM。PI-103 Hydrochloride 也可抑制DNA-PK,IC50 为 2 nM。PI-103 Hydrochloride 诱导自噬 (autophagy)
    PI-103 Hydrochloride
  • HY-14581
    Palomid 529 Inhibitor 99.47%
    Palomid 529 是一种有效的 mTORC1mTORC2 复合体抑制剂。
    Palomid 529
  • HY-100026
    PQR620 Inhibitor 98.01%
    PQR620 是一种有效的,具有口服活性的可透过血脑屏障的选择性 mTORC1/2 抑制剂。
    PQR620
  • HY-114414
    HDACs/mTOR Inhibitor 1 Inhibitor 98.21%
    HDACs/mTOR Inhibitor 1 是一种双重的 HDAC.html" class="link-product" target="_blank">HDACs 和 mTOR.html" class="link-product" target="_blank">mTOR 抑制剂,对 HDAC1, HDAC6, mTORIC50s 分别为 0.19 nM、1.8 nM、1.2 nM。HDACs/mTOR Inhibitor 1 刺激细胞周期停滞在 G0/G1 期并诱导肿瘤细胞凋亡,且 in vivo 毒性低。HDACs/mTOR Inhibitor 1 可用于血液系统恶性肿瘤的研究。
    HDACs/mTOR Inhibitor 1
  • HY-15272
    WAY-600 Inhibitor 99.75%
    WAY-600 是有效,ATP 竞争型,选择性的 mTOR 抑制剂,抑制重组 mTOR 酶的 IC50 值为 9 nM。WAY-600 阻断 mTOR 复合物 1/2 (mTORC1/2) 组装和激活。
    WAY-600
  • HY-N2217
    Rotundic acid

    铁冬青酸

    Inhibitor 99.41%
    Rotundic acid 是一种从铁冬青 (Ilex rotunda Thunb) 中获得的三萜类化合物,可通过 AKT/mTORMAPK 途径在肝细胞癌中诱导 DNA 损伤和细胞凋亡。Rotundic acid 具有抗炎和保护心脏的能力。
    Rotundic acid
  • HY-109046
    Tulrampator 98.92%
    Tulrampator (S-47445) 是有口服活性的,选择性的 AMPA receptor 调节剂,Tulrampator 具有促认知、增强突触可塑性、抗抑郁、抗焦虑、促认知和潜在的神经保护作用,并且可用于阿尔茨海默病和重性抑郁障碍的研究。
    Tulrampator
  • HY-110109
    ETP-45658 Inhibitor 98.05%
    ETP-45658 是一种有效的 PI3K 抑制剂,抑制 PI3KαPI3KδPI3KβPI3KγIC50 值分别为 22.0 nM,39.8 nM,129.0 nM 和 717.3 nM。ETP-45658 还可以抑制 DNA-PK (IC50=70.6 nM) 和 mTOR (IC50=152.0 nM)。ETP-45658 可用于癌症研究。
    ETP-45658
  • HY-W058849
    MT 63-78 Inhibitor 98.50%
    MT 63-78 是一种有效的直接 AMPK 激活剂,EC50 为 25 μM。M 63-78 还诱导细胞有丝分裂阻滞和细胞凋亡 (apoptosis)。MT 63-78 通过抑制脂肪生成和 mTORC1 途径来阻止前列腺癌的生长。MT 63-78 具有抗肿瘤作用。
    MT 63-78
  • HY-137175
    TMBIM6 antagonist-1 Antagonist 99.60%
    TMBIM6 antagonist-1 是一个有潜力的 TMBIM6 拮抗剂,抑制 TMBIM6 与 mTORC2 结合,降低 mTORC2 活性,调节TMBIM6 释放 Ca2+
    TMBIM6 antagonist-1
目录号 产品名 / 同用名 应用 反应物种

The mammalian target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation and survival[1]. mTOR is the catalytic subunit of two distinct complexes called mTORC1 and mTORC2. mTORC1 comprises DEPTOR, PRAS40, RAPTOR, mLST8, mTOR, whereas mTORC2 comprises DEPTOR, mLST8, PROTOR, RICTOR, mSIN1, mTOR[2]. Rapamycin binds to FKBP12 and inhibits mTORC1 by disrupting the interaction between mTOR and RAPTOR. mTORC1 negatively regulates autophagy through multiple inputs, including inhibitory phosphorylation of ULK1 and TFEB. mTORC1 promotes protein synthesis through activation of the translation initiation promoter S6K and through inhibition of the inhibitory mRNA cap binding 4E-BP1, and regulates glycolysis through HIF-1α. It promotes de novo lipid synthesis through the SREBP transcription factors. mTORC2 inhibits FOXO1,3 through SGK and Akt, which can lead to increased longevity. The complex also regulates actin cytoskeleton assembly through PKC and Rho kinase[3]

 

Growth factors: Growth factors can signal to mTORC1 through both PI3K-Akt and Ras-Raf-MEK-ERK axis. For example, ERK and RSK phosphorylate TSC2, and inhibit it.

 

Insulin Receptor: The activated insulin receptor recruits intracellular adaptor protein IRS1. Phosphorylation of these proteins on tyrosine residues by the insulin receptor initiates the recruitment and activation of PI3K. PIP3 acts as a second messenger which promotes the phosphorylation of Akt and triggers the Akt-dependent multisite phosphorylation of TSC2. TSC is a heterotrimeric complex comprised of TSC1, TSC2, and TBC1D7, and functions as a GTPase activating protein (GAP) for the small GTPase Rheb, which directly binds and activates mTORC1. mTORC2 primarily functions as an effector of insulin/PI3K signaling. 

 

Wnt: The Wnt pathway activates mTORC1. Glycogen synthase kinase 3β (GSK-3β) acts as a negative regulator of mTORC1 by phosphorylating TSC2. mTORC2 is activated by Wnt in a manner dependent on the small GTPase RAC1[4].

 

Amino acids: mTORC1 senses both lysosomal and cytosolic amino acids through distinct mechanisms. Amino acids induce the movement of mTORC1 to lysosomal membranes, where the Rag proteins reside. A complex named Ragulator, interact with the Rag GTPases, recruits them to lysosomes through a mechanism dependent on the lysosomal v-ATPase, and is essential for mTORC1 activation. In turn, lysosomal recruitment enables mTORC1 to interact with GTP-bound RHEB, the end point of growth factor. Cytosolic leucine and arginine signal to mTORC1 through a distinct pathway comprised of the GATOR1 and GATOR2 complexes.    

 

Stresses: mTORC1 responds to intracellular and environmental stresses that are incompatible with growth such as low ATP levels, hypoxia, or DNA damage. A reduction in cellular energy charge, for example during glucose deprivation, activates the stress responsive metabolic regulator AMPK, which inhibits mTORC1 both indirectly, through phosphorylation and activation of TSC2, as well as directly through the phosphorylation of RAPTOR. Sestrin1/2 are two transcriptional targets of p53 that are implicated in the DNA damage response, and they potently activate AMPK, thus mediating the p53-dependent suppression of mTOR activity upon DNA damage. During hypoxia, mitochondrial respiration is impaired, leading to low ATP levels and activation of AMPK. Hypoxia also affects mTORC1 in AMPK-independent ways by inducing the expression of REDD1, the protein products of which then suppress mTORC1 by promoting the assembly of TSC1-TSC2[2].

 

Reference:

[1]. Laplante M, et al.mTOR signaling at a glance.J Cell Sci. 2009 Oct 15;122(Pt 20):3589-94. 
[2]. Zoncu R, et al. mTOR: from growth signal integration to cancer, diabetes and ageing.Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. 
[3]. Johnson SC, et al. mTOR is a key modulator of ageing and age-related disease.Nature. 2013 Jan 17;493(7432):338-45.
[4]. Shimobayashi M, et al. Making new contacts: the mTOR network in metabolism and signalling crosstalk.Nat Rev Mol Cell Biol. 2014 Mar;15(3):155-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.